Xiidra Approved; Pending Effective Date

Posted in Latest News on September 14, 2016.

At the August 19, 2016 Board of Optometry meeting, the board voted and approved the use of Xiidra (Lifitegrast ophthalmic solution 5%) for dry eyes. The formulary rule is in the process of being changed to include Lifitegrast ophthalmic solution 5%.

Until the new rule becomes effective, Florida Optometrists are not allowed to prescribe the medication. The board will place a notification on the website advising when the addition to the rule has become effective.



More Latest News

Second Quarter Performance Report
April 12, 2022

Released for the
2022 – 2023 Fiscal Year Continue reading


Fraudulent Email Alert
February 23, 2022

The Department of Health, Division of Medical Quality Assurance, is warning Florida health care practitioners about fraudulent emails that have been received by multiple licensees. Continue reading